Staging prostate cancer--1997: current methods and limitations.
about
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens.Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL.Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.miR-27a in serum acts as biomarker for prostate cancer detection and promotes cell proliferation by targeting Sprouty2
P2860
Staging prostate cancer--1997: current methods and limitations.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Staging prostate cancer--1997: current methods and limitations.
@en
Staging prostate cancer--1997: current methods and limitations.
@nl
type
label
Staging prostate cancer--1997: current methods and limitations.
@en
Staging prostate cancer--1997: current methods and limitations.
@nl
prefLabel
Staging prostate cancer--1997: current methods and limitations.
@en
Staging prostate cancer--1997: current methods and limitations.
@nl
P1433
P1476
Staging prostate cancer--1997: current methods and limitations
@en
P2093
Bostwick DG
P407
P478
32 Suppl 3
P577
1997-01-01T00:00:00Z